Eli Lilly, Elan Get $8M In Fees After Alzheimer's IP Win
A California federal judge on Friday ordered the Alzheimer's Institute of America to pay Eli Lilly and Elan Pharmaceuticals roughly $8 million in attorneys' fees after losing a suit backed by...To view the full article, register now.
Already a subscriber? Click here to view full article